Viscoelastic Testing

It has been a privilege and a pleasure to support nearly all of Andreas’s innovations over the past 15 years. The journey from the early days of innovation to today's MultiClot system is not only a testament to technological excellence but also to the persistence of a vision rooted in clinical relevance and collaboration. This new platform represents more than just technical progress—it reflects the collective wisdom of decades of development, multidisciplinary input, and fro

A recent proof-of-concept study published in Neurol. Int. 2025 has assessed the effectiveness of ClotPro® viscoelastic point-of-care testing in quickly evaluating DOAC activity among acute ischemic stroke patients to assist in intravenous thrombolysis (IVT) decisions. ClotPro® successfully identified 37.5% (15 patients) as having subtherapeutic levels, allowing 7 of them to undergo IVT. This highlights the potential of real-time whole blood hemostatic assessment at the point

A nice review of viscoelastic devices including the #ClotPro which has the advantage of having the largest panel of tests including...

Great to see our two products #Multiplate and #ClotPro in this recent study just published in Anesthesia journal to assess the...

In addition to established thromboelastometry assays, #ClotPro provides a unique assay that can evaluate the inhibitory effect on Xa...

The authors review major studies that have assessed fibrinogen treatment in trauma, cardiac surgery, end-stage liver disease, postpartum hem